Technology News and Research

RSS

Merck granted exclusive license to Pfenex' Pseudomonas-based protein expression technology

Pfenex Inc. announced today that it has granted Merck & Co., Inc., through an affiliate, an exclusive worldwide license to Pfenex Expression Technology(TM) Pseudomonas-based recombinant protein expression technology for the production of specific proteins to be used in the development of an undisclosed vaccine candidate.

15 Dec 2009

HealthPort's RACPro now holds the distinction of being RACTrac Compatible

HealthPort®, Inc., a top 25-company in the healthcare information technology industry, today announced its recovery audit contractor (RAC) management tool, HealthPort RACPro, now holds the distinction, through the American Hospital Association (AHA), of being RACTrac Compatible.

15 Dec 2009

Geron’s request for declaration of interference regarding Novocell' U.S. Patent No. 7,510,876 granted

Geron Corporation today announced that the U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences, has granted Geron’s request to declare an interference between a patent application owned by Geron and U.S. Patent No. 7,510,876 (the ‘876 patent) owned by Novocell, Inc.

15 Dec 2009

Hospitals to find acceptable alternatives to STERIS System 1 sterile processing system

In response to an FDA notice issued on December 3, 2009, in which the Agency recommended that healthcare facilities discontinue use of the STERIS System 1® (SS1) sterile processing system, hospitals throughout the U.S. are faced with the task of finding acceptable alternatives to that product.

15 Dec 2009

ProChon Biotech announces expansion of BioCart Cartilage Regeneration System study

ProChon Biotech, Ltd., an innovator of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality of life for sufferers of articular cartilage injuries, today announced a significant expansion of its clinical study of the BioCart™ Cartilage Regeneration System.

15 Dec 2009

New highly sensitive CFSE T cell proliferation assays launched by ProImmune

ProImmune Ltd, a leader in epitope discovery, immunogenicity and immune monitoring products and services, has launched CFSE T cell proliferation assays for immunogenicity risk assessment. The new highly sensitive assays form part of ProImmune’s REVEAL Immunogenicity System, a suite of tools used in the design and selection of biological drug leads at the preclinical stage.

15 Dec 2009

Nanoparticle could allow diagnosis and treatment in one visit

Researchers at Rice University and Baylor College of Medicine (BCM) have created a single nanoparticle that can be tracked in real time with MRI as it homes in on cancer cells, tags them with a fluorescent dye and kills them with heat.

15 Dec 2009

Health experts discuss new treatment strategies for lung cancer at AACR-IASLC Joint Conference

In partnership with the International Association for the Study of Lung Cancer, the American Association for Cancer Research will host the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, which will bring together leaders from all over the world who share the goal of eradicating this form of cancer.

15 Dec 2009

Sword Diagnostics receives patent on improved sensitivity technology for detection of biological organisms

Sword Diagnostics, Inc. is pleased to announce that the United States Patent Office (USPTO) has issued patent number 7,599,057 titled "Method and Apparatus for Detection of Biological Organisms using Raman Scattering" to the company.

15 Dec 2009

Mediware Information Systems acquires two software companies

Mediware Information Systems, Inc. announced today that it has finalized the acquisitions of Healthcare Automation Inc. (HAI) and Advantage Reimbursement Inc. (ARI), which provides software and outsourcing solutions for home health providers.

15 Dec 2009

Rexahn Pharmaceuticals and TheraTarget sign joint research collaboration agreement

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, and TheraTarget, Inc., a developer of innovative polymer therapeutics for the treatment of cancer, today announced the formation of a joint research collaboration agreement.

15 Dec 2009

Perry Baromedical announces the launch of Sigma Elite

Perry Baromedical, international leader in Hyperbaric Chamber manufacturing for 40 years, announces the launch of the Sigma Elite, with extended patient data capture capability.

15 Dec 2009

Bio-Quant becomes wholly-owned subsidiary of NexMed

NexMed, Inc., a developer of products based on the NexACT® technology, today announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA. Upon closing, Bio-Quant became a wholly-owned subsidiary of NexMed.

15 Dec 2009

UT Southwestern Medical Center performs minimally invasive procedures for sinuses and chronic rhinosinusitis

Only about one in 2,000 people in the United States get a sinus tumor, but Johnnie Wilcox was one of the unfortunate few.

15 Dec 2009

Dyadic International enters into collaboration agreement with The Scripps Research Institute

Dyadic International, Inc. ("Dyadic") announced today that it has extended its collaboration with The Scripps Research Institute ("Scripps") by entering into an agreement with Scripps to re-annotate the genome of Dyadic's patented and proprietary C1 fungus ("C1").

15 Dec 2009

Varian Medical Systems introduces RapidArc radiotherapy technology in Finland

Cancer patients in Finland have gained access to more advanced treatments with the introduction of RapidArc® radiotherapy technology from Varian Medical Systems at the only private radiotherapy clinic in the Nordic region.

15 Dec 2009

ALS TDI and Applied Proteomics join to identify protein biomarkers associated with ALS

The ALS Therapy Development Institute (ALS TDI) and Applied Proteomics, Inc. announced today that they have completed the first stage of a multi-year collaboration to identify and validate protein biomarkers associated with amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease).

15 Dec 2009

Technology News and Research

Merck granted exclusive license to Pfenex' Pseudomonas-based protein expression technology

HealthPort's RACPro now holds the distinction of being RACTrac Compatible

Geron’s request for declaration of interference regarding Novocell' U.S. Patent No. 7,510,876 granted

Hospitals to find acceptable alternatives to STERIS System 1 sterile processing system

ProChon Biotech announces expansion of BioCart Cartilage Regeneration System study

New highly sensitive CFSE T cell proliferation assays launched by ProImmune

Nanoparticle could allow diagnosis and treatment in one visit

Health experts discuss new treatment strategies for lung cancer at AACR-IASLC Joint Conference

Sword Diagnostics receives patent on improved sensitivity technology for detection of biological organisms

Mediware Information Systems acquires two software companies

Rexahn Pharmaceuticals and TheraTarget sign joint research collaboration agreement

Perry Baromedical announces the launch of Sigma Elite

Bio-Quant becomes wholly-owned subsidiary of NexMed

UT Southwestern Medical Center performs minimally invasive procedures for sinuses and chronic rhinosinusitis

Dyadic International enters into collaboration agreement with The Scripps Research Institute

Varian Medical Systems introduces RapidArc radiotherapy technology in Finland

ALS TDI and Applied Proteomics join to identify protein biomarkers associated with ALS

Alexza Pharmaceuticals submits its NDA for Staccato loxapine to FDA

Ted and Jane Von Voigtlander Foundation gifts $15 million to University of Michigan Health System

Experts consider public option compromise, role of OPM in health bill

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News